175 related articles for article (PubMed ID: 28389140)
1. Sex differences in aripiprazole sensitization from adolescence to adulthood.
Freeman E; Lin J; Chow S; Davis C; Li M
Pharmacol Biochem Behav; 2017 May; 156():39-47. PubMed ID: 28389140
[TBL] [Abstract][Full Text] [Related]
2. Adult response to olanzapine or clozapine treatment is altered by adolescent antipsychotic exposure: a preclinical test in the phencyclidine hyperlocomotion model.
Shu Q; Hu G; Li M
J Psychopharmacol; 2014 Apr; 28(4):363-75. PubMed ID: 24257809
[TBL] [Abstract][Full Text] [Related]
3. Olanzapine sensitization and clozapine tolerance: from adolescence to adulthood in the conditioned avoidance response model.
Qiao J; Li H; Li M
Neuropsychopharmacology; 2013 Feb; 38(3):513-24. PubMed ID: 23132270
[TBL] [Abstract][Full Text] [Related]
4. Repeated administration of aripiprazole produces a sensitization effect in the suppression of avoidance responding and phencyclidine-induced hyperlocomotion and increases D2 receptor-mediated behavioral function.
Gao J; Qin R; Li M
J Psychopharmacol; 2015 Apr; 29(4):390-400. PubMed ID: 25586399
[TBL] [Abstract][Full Text] [Related]
5. Long-term impacts of adolescent risperidone treatment on behavioral responsiveness to olanzapine and clozapine in adulthood.
Qiao J; Zhang Q; Li M
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():177-85. PubMed ID: 24140929
[TBL] [Abstract][Full Text] [Related]
6. Repeated asenapine treatment produces a sensitization effect in two preclinical tests of antipsychotic activity.
Qin R; Chen Y; Li M
Neuropharmacology; 2013 Dec; 75():356-64. PubMed ID: 23954676
[TBL] [Abstract][Full Text] [Related]
7. Contextual and behavioral control of antipsychotic sensitization induced by haloperidol and olanzapine.
Zhang C; Li M
Behav Pharmacol; 2012 Feb; 23(1):66-79. PubMed ID: 22157143
[TBL] [Abstract][Full Text] [Related]
8. Long-lasting sensitization induced by repeated risperidone treatment in adolescent Sprague-Dawley rats: a possible D2 receptor mediated phenomenon?
Qiao J; Gao J; Shu Q; Zhang Q; Hu G; Li M
Psychopharmacology (Berl); 2014 Apr; 231(8):1649-1659. PubMed ID: 24363078
[TBL] [Abstract][Full Text] [Related]
9. Repeated effects of the neurotensin receptor agonist PD149163 in three animal tests of antipsychotic activity: assessing for tolerance and cross-tolerance to clozapine.
Chou S; Davis C; Jones S; Li M
Pharmacol Biochem Behav; 2015 Jan; 128():78-88. PubMed ID: 25433325
[TBL] [Abstract][Full Text] [Related]
10. Time-dependent sensitization of antipsychotic effect in adolescent male and female rats.
Ding X; Li X; Shu Q; Wu R; Hu G; Li M
Behav Brain Res; 2017 Jun; 328():186-194. PubMed ID: 28412306
[TBL] [Abstract][Full Text] [Related]
11. Maternal immune activation and repeated maternal separation alter offspring conditioned avoidance response learning and antipsychotic response in male rats.
Chou S; Davis C; Li M
Behav Brain Res; 2021 Apr; 403():113145. PubMed ID: 33515643
[TBL] [Abstract][Full Text] [Related]
12. Neural basis of the potentiated inhibition of repeated haloperidol and clozapine treatment on the phencyclidine-induced hyperlocomotion.
Zhao C; Sun T; Li M
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Aug; 38(2):175-82. PubMed ID: 22476004
[TBL] [Abstract][Full Text] [Related]
13. Asenapine sensitization from adolescence to adulthood and its potential molecular basis.
Shu Q; Qin R; Chen Y; Hu G; Li M
Behav Brain Res; 2014 Oct; 273():166-76. PubMed ID: 25093543
[TBL] [Abstract][Full Text] [Related]
14. Adolescent olanzapine sensitization is correlated with hippocampal stem cell proliferation in a maternal immune activation rat model of schizophrenia.
Chou S; Jones S; Li M
Brain Res; 2015 Aug; 1618():122-35. PubMed ID: 26049127
[TBL] [Abstract][Full Text] [Related]
15. Continuous oral olanzapine or clozapine treatment initiated in adolescence has differential short- and long-term impacts on antipsychotic sensitivity than those initiated in adulthood.
Wu R; Chou S; Li M
Eur J Pharmacol; 2024 Jun; 972():176567. PubMed ID: 38582275
[TBL] [Abstract][Full Text] [Related]
16. Repeated antipsychotic treatment progressively potentiates inhibition on phencyclidine-induced hyperlocomotion, but attenuates inhibition on amphetamine-induced hyperlocomotion: relevance to animal models of antipsychotic drugs.
Sun T; Hu G; Li M
Eur J Pharmacol; 2009 Jan; 602(2-3):334-42. PubMed ID: 19059234
[TBL] [Abstract][Full Text] [Related]
17. Time-dependence of risperidone and asenapine sensitization and associated D2 receptor mechanism.
Gao J; Li M
Behav Brain Res; 2013 Nov; 257():286-94. PubMed ID: 24103641
[TBL] [Abstract][Full Text] [Related]
18. Environmental and behavioral controls of the expression of clozapine tolerance: evidence from a novel across-model transfer paradigm.
Feng M; Sui N; Li M
Behav Brain Res; 2013 Feb; 238():178-87. PubMed ID: 23092709
[TBL] [Abstract][Full Text] [Related]
19. Effect of environmental cues on the behavioral efficacy of haloperidol, olanzapine, and clozapine in rats.
Sun T; Liu X; Li M
Behav Pharmacol; 2014 Aug; 25(4):277-86. PubMed ID: 24949569
[TBL] [Abstract][Full Text] [Related]
20. Olanzapine and risperidone disrupt conditioned avoidance responding in phencyclidine-pretreated or amphetamine-pretreated rats by selectively weakening motivational salience of conditioned stimulus.
Li M; He W; Mead A
Behav Pharmacol; 2009 Feb; 20(1):84-98. PubMed ID: 19179852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
